Abstract
The advent of transcatheter procedures for treatment of valvular heart disease has accelerated the pace of research in the diagnosis and treatment of heart valve disease. Rapid accumulation of novel knowledge in the field necessitates timely revisions of clinical guidelines. This paper comments on some important and novel issues addressed in the recently published American College of Cardiology/American Heart Association (ACC/AHA) guidelines.
Originalsprache | Englisch |
---|---|
Seiten (von - bis) | 786-789 |
Seitenumfang | 4 |
Fachzeitschrift | Wiener Klinische Wochenschrift |
Jahrgang | 133 |
Ausgabenummer | 15-16 |
DOIs | |
Publikationsstatus | Veröffentlicht - Aug. 2021 |